GlobeNewswire Inc.··Cogent Biosciences, Inc.Cogent Biosciences Showcases Dual Pipeline Advances at AACR 2026 Meeting
Cogent Biosciences highlights preclinical data for KRAS and HER2 inhibitors at AACR 2026, with IND submission planned for CGT1263.
COGTIND submissionAACR Annual Meeting